Immunological quantitation of DT-diaphorase in carcinoma cell lines and clinical colon cancers: Advanced tumors express greater levels of DT-diaphorase

Japanese Journal of Cancer Research

Volumn 89, Issue 9, 1998, Pages 910-915

  Mikami, Koji ^a,b   Naito, Mikihiko ^a   Ishiguro, Tatsuaki ^a   Yano, Hideaki ^a   Tomida, Akihiro ^a   Yamada, Takeshi ^c   Tanaka, Noritake ^c   Shirakusa, Takayuki ^b   Tsuruo, Takashi ^a,d  

^a UNIVERSITY OF TOKYO   (Japan)

^b FUKUOKA UNIVERSITY   (Japan)

^c NIPPON MEDICAL SCHOOL   (Japan)

^d CANCER CHEMOTHERAPY CENTER   (Japan)

Author keywords

Colon carcinoma; DT diaphorase; Immunoblot; Metastasis; Mitomycin C

Indexed keywords

DRUG METABOLIZING ENZYME; ENZYME ANTIBODY; MITOMYCIN C; MONOCLONAL ANTIBODY; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE);

ADVANCED CANCER; ARTICLE; CARCINOMA CELL; COLON CANCER; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0031791376     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1998.tb00648.x     Document Type: Article

References (23)

1. Tomasz, M. and Lipman, R. Reductive mechanism and alkylating activity of mitomycin C induced by rat liver microsomes. Biochemistry, 20, 5056-5061 (1981).
2. Pan, S. S., Andrews, P. A., Glover, C. J. and Bachur, N. R. Reductive activation of mitomycin C and mitomycin C metabolites catalyzed by NADPH-cytochrome P-450 reductase and xanthine oxidase. J. Biol. Chem., 259, 959-966 (1984).
3. Hodnick, W. F. and Sartorelli, A. C. Reductive activation of mitomycin C by NADH:cytochrome b5 reductase. Cancer Res., 53, 4907-4912 (1993).
4. Gustafson, D. L. and Pritsos, C. A. Enhancement of xanthine dehydrogenase mediated mitomycin C metabolism by dicoumarol. Cancer Res., 52, 6936-6939 (1992).
5. Jaiswal, A. K., McBride, O. W., Adesnik, M. and Nebert, D. W. Human dioxin inducible cytosolic NAD(P)H:menadione oxidoreductase. cDNA sequence and localization of gene to chromosome 16. J. Biol. Chem., 263, 13572-13578 (1988).
6. Pan, S. S., Forrest, G. L., Akman, S. A. and Hu, L. T. NAD(P)H:quinone oxidoreductase expression and mitomycin C resistance developed by human colon cancer HCT 116 cells. Cancer Res., 55, 330-335 (1995).
7. Traver, R. D., Horikoshi, T., Danenberg, K. D., Stadlbauer, T. H., Danenberg, P. V., Ross, D. and Gibson, N. W. NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity. Cancer Res., 52, 797-802 (1992).
8. Marshall, R. S., Paterson, M. C. and Rauth, A. M. Deficient activation by a human cell strain leads to mitomycin resistance under aerobic but not hypoxic conditions. Br. J. Cancer, 59, 341-346 (1989).
9. Keyes, S. R., Rockwell, S. and Sartorelli, A. C. Enhancement of mitomycin C cytotoxicity to hypoxic tumor cells by dicoumarol in vivo and in vitro. Cancer Res., 45, 213-216 (1985).
10. Siegel, D., Gibson, N. W., Preusch, P. C. and Ross, D. Metabolism of mitomycin C by DT-diaphorase: role in mitomycin C-induced DNA damage and cytotoxicity in human colon carcinoma cells. Cancer Res., 50, 7483-7489 (1990).
11. Begleiter, A., Robotham, E., Lacey, G. and Leith, M. K. Increased sensitivity of quinone resistant cells to mitomycin C. Cancer Lett., 45, 173-176 (1989).
12. Rockwell, S., Keyes, S. R. and Sartorelli, A. C. Modulation of the cytotoxicity of mitomycin C to EMT6 mouse mammary tumor cells by dicoumarol in vitro. Cancer Res., 48, 5471-5474 (1988).
13. Fitzsimmons, S. A., Workman, P., Grever, M., Paull, K., Camalier, R. and Lewis, A. D. Reductase enzyme expression across the National Cancer Institute tumor cell line panel: correlation with sensitivity to mitomycin C and EO9. J. Natl. Cancer Inst., 88, 259-269 (1996).
14. Lee, J. H., Naito, M., Nakajima, M. and Tsuruo, T. Isolation and characterization of a mitomycin C-resistant variant of human colon carcinoma HT-29 cells. Cancer Chemother. Pharmacol., 33, 215-220 (1993).
15. Mikami, K., Naito, M., Tomida, A., Yamada, M., Sirakusa, T. and Tsuruo, T. DT-diaphorase as a critical determinant of sensitivity to mitomycin C in human colon and gastric carcinoma cell lines. Cancer Res., 56, 2823-2826 (1996).
16. Ernster, L. DT-diaphorase. Methods Enzymol., 10, 309-317 (1967).
17. Watanabe, M., Komeshima, N., Naito, M., Isoe, T., Otake, N. and Tsuruo, T. Cellular pharmacology of MX2, a new morpholino anthracycline, in human pleiotropic drug-resistant cells. Cancer Res., 51, 157-161 (1991).
18. Tsuruo, T., Iida, H., Tsukagoshi, S. and Sakurai, Y. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res., 41, 1967-1972 (1981).
19. Benson, A. M., Hunkeler, M. J., and Talalay, P. Increase of NAD(P)H:quinone reductase by dietary antioxidants: possible role in protection against carcinogenesis and toxicity. Proc. Natl. Acad. Sci. USA, 77, 5216-5220 (1980).
20. Schor, N. A. and Cornelisse, C. J. Biochemical and quantitative histochemical study of reduced pyridine nucleotide dehydrogenation by human colonie carcinoma. Cancer Res., 43, 4850-4855 (1983).
21. Schlager, J. J. and Powis, G. Cytosolic NAD(P)H:(quinone-acceptor) oxidoreductase in human normal and tumor tissue: effects of cigarette smoking and alcohol. Int. J. Cancer, 45, 403-409 (1990).
22. de Waziers, I., Cugnenc, P. H., Berger, A., Leroux, J. P. and Beaune, P. H. Drug-metabolizing enzyme expression in human normal peritumoral and tumoral colorectal tissue samples. Carcinogenesis, 12, 905-909 (1991).
23. Cresteil, T. and Jaiswal, A. K. High levels of expression of the NAD(P)H:quinone oxidoreductase (NQO1) gene in tumor cells compared to normal cells of the same origin. Biochem. Pharmacol., 42, 1021-1027 (1991).